In Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., the Supreme Court held that allegations based on a generic manufacturer’s skinny label, website statements, patient leaflet and press releases ...

Jack Caporal is the Research Director for The Motley Fool and Motley Fool Money and has worked full-time for the company since 2021. Jack leads efforts to identify and analyze trends shaping investing ...

More than three decades after Rachel Nickell's murder shocked Britain, her story is once again in the spotlight. But unlike previous retellings, the latest adaptations focus not only on the 1992 ...

In a unanimous decision with immediate consequences for Hatch‑Waxman litigation, the U.S. Supreme Court has significantly narrowed the scope of induced patent infringement under 35 U.S.C. Section ...

June 5 (Reuters) - The world's largest instrumental musicians union sued Warner Music Group (WMG.O), opens new tab and Universal Music Group (UMG.AS), opens new tab in Manhattan federal court on ...

Regarding the presence or absence of inducement infringement for the Skinny Label introduced in the article below, the U.S. Supreme Court handed down a ruling on June 4. The ruling states that ...

Microsoft Threat Intelligence discovered that Anthropic’s Claude Code GitHub Action could expose CI/CD workflow secrets when AI agents process untrusted GitHub content, including issue bodies, pull ...

Hikma Pharmaceuticals didn’t run afoul of patent law in marketing a copycat version of Amarin’s heart drug Vascepa, the Supreme Court ruled Thursday, in a decision that could help protect makers of ...

WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's generic version of Amarin Pharma's cardiovascular medication Vascepa did not infringe Amarin's patents, the U.S. Supreme Court ruled on Thursday in a ...

With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic version of Amarin’s fish oil-derived cardiovascular drug Vascepa does not ...

WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's (HIK.L), opens new tab generic version of Amarin Pharma's (AMRN.O), opens new tab cardiovascular medication Vascepa did not infringe Amarin's patents, ...